PDL BioPharma, Inc. Fair Value Inputs, Revenue Multiple (Deprecated 2018-01-31)
PDL BioPharma, Inc. reported Fair Value Inputs, Revenue Multiple (Deprecated 2018-01-31) of 300.00% for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Income Statement › Other Income
us-gaap:FairValueInputsRevenueMultiple · last filed 2013-11-06
- PDL BioPharma, Inc. fair value inputs, revenue multiple (deprecated 2018-01-31) for the quarter ending 2013-09-30 was 300.00%.
- PDL BioPharma, Inc. fair value inputs, revenue multiple (deprecated 2018-01-31) for the quarter ending 2013-06-30 was 300.00%.
- PDL BioPharma, Inc. fair value inputs, revenue multiple (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 300.00%.
- PDL BioPharma, Inc. fair value inputs, revenue multiple (deprecated 2018-01-31) for fiscal 2012 was 300.00%.
| Period end | Fair Value Inputs, Revenue Multiple (Deprecated 2018-01-31) 3 month | Fair Value Inputs, Revenue Multiple (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2013-09-30 | 300.00% 10-Q · filed 2013-11-06 | |
| 2013-06-30 | 300.00% 10-Q · filed 2013-08-08 | |
| 2013-03-31 | 300.00% 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 300.00% 10-K · filed 2013-03-01 |